AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative ... filed to list on the ...

A groundbreaking antibiotic discovery might finally tip the balance in the global fight against drug-resistant bacteria.